Trial Profile
Bortezomib in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2014
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Acronyms CREST; SUMMIT
- 05 Nov 2010 New trial record.